Catalent, Inc.
Catalent, Inc. (CTLT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CTLT · as of Dec 31, 2024
Ownership Breakdown
8
Institutional Holders
▼ 490 vs Q3
$11.28M
Total Inst. Value
▼ $10.77B vs Q3
181.51M
Shares Outstanding
freeFloat 99.37%
183,590
13F Shares Held
▼ 177.94M vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CTLT largest shareholders · institutional ownership
Q4 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BARCLAYS PLC pharmaceutical preparations | 116.9K | 6.42% | 6.42% | $7.42B | Mar 19, 2026 | ▼ 4.17M |
DEKABANK DEUTSCHE GIROZENTRALE pharmaceutical preparations | 31.7K | 1.74% | 1.74% | $1.71B | Jan 29, 2025 | — held |
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 24.8K | 1.36% | 1.36% | $1.50B | Feb 7, 2025 | ▼ 3.6K |
RESONA ASSET MANAGEMENT CO.,LTD. pharmaceutical preparations | 9.3K | 0.51% | 0.51% | $590.55M | Feb 13, 2025 | ▼ 46.4K |
RONALD BLUE TRUST, INC. pharmaceutical preparations | 615 | 0.03% | 0.03% | $37.25M | Jan 22, 2025 | ▲ 289 |
IFP ADVISORS, INC pharmaceutical preparations | 187 | 0.01% | 0.01% | $13.14M | Feb 4, 2025 | ▲ 23 |
EAGLE BAY ADVISORS LLC pharmaceutical preparations | 5 | 0.00% | 0.00% | $317,000 | Jan 13, 2025 | ▼ 66 |
HUNTINGTON NATIONAL BANK pharmaceutical preparations | 1 | 0.00% | 0.00% | $63,000 | Feb 12, 2025 | ▼ 266 |
M&T BANK CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 6, 2025 | EXIT |
US BANCORP \DE\ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 5, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2024 vs prior quarter
Q4 2024
2
Increased
+312 shares0
New Positions
first time holders5
Decreased
−4.22M shares42
Sold Out
fully exitedNet shares change (top 50)
4.22M
+312 / −4.22M
Net new holders
-45
0 new / 42 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CTLT insider trading · insider activity
Source: SEC Form 4
20
Buy transactions
41
Sell transactions
0.49
Buy/Sell ratio
$1M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Gennadios Aristippos Group Pres. Pharma & Consumer | Dec 18, 2024 | Award | 21,562 | — | — | 21.6K | Form 4 ↗ |
Gennadios Aristippos Group Pres. Pharma & Consumer | Dec 18, 2024 | D-Return | 21,562 | — | — | 0 | Form 4 ↗ |
McErlane David Group President, Biologics | Dec 18, 2024 | Award | 11,426 | — | — | 11.4K | Form 4 ↗ |
McErlane David Group President, Biologics | Dec 18, 2024 | D-Return | 14,740 | $45.79 | $674.9K | 0 | Form 4 ↗ |
McErlane David Group President, Biologics | Dec 18, 2024 | D-Return | 11,426 | — | — | 0 | Form 4 ↗ |
Hatzfeld Michael Chief Accounting Officer | Dec 18, 2024 | Award | 3,144 | — | — | 3.1K | Form 4 ↗ |
Hatzfeld Michael Chief Accounting Officer | Dec 18, 2024 | D-Return | 3,144 | — | — | 0 | Form 4 ↗ |
Gunther Scott SVP, Quality & Reg. Affairs | Dec 18, 2024 | Award | 12,938 | — | — | 12.9K | Form 4 ↗ |
Gunther Scott SVP, Quality & Reg. Affairs | Dec 18, 2024 | D-Return | 12,938 | — | — | 0 | Form 4 ↗ |
Ferraro Joseph Anthony SVP, General Counsel, CCO | Dec 18, 2024 | Award | 14,265 | — | — | 14.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Catalent, Inc. (CTLT) is primarily owned by institutional investors, who hold approximately 0.1% of total shares outstanding. Company insiders own approximately 0.63%, while retail and public investors account for the remaining 99.27%.
The largest institutional shareholder of Catalent, Inc. is BARCLAYS PLC, holding approximately 116,895 shares — equal to 6.42% of outstanding shares — as of December 31, 2024.
A total of 8 institutional investors currently hold CTLT stock, with a combined institutional value of approximately $11,275,489 as of the most recent 13F filing period.
Frequently asked questions
CTLT ownershipCatalent, Inc. (CTLT) is primarily owned by institutional investors, who hold approximately 0.1% of shares. The largest shareholder is BARCLAYS PLC with a 6.42% stake. Company insiders hold 0.63%. Data sourced from SEC Form 13F as of December 31, 2024.